Advertisement

Topics

Immunotherapy for Type 1 Diabetes Safe in Small Study

10:17 EDT 10 Aug 2017 | Medscape

Proinsulin peptide immunotherapy for newly diagnosed type 1 diabetes appeared safe and tolerable in a phase 1b safety clinical trial; it could be used like allergy desensitization in the future.
Medscape Medical News

Original Article: Immunotherapy for Type 1 Diabetes Safe in Small Study

NEXT ARTICLE

More From BioPortfolio on "Immunotherapy for Type 1 Diabetes Safe in Small Study"

Quick Search
Advertisement
 

Relevant Topics

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...